Revolution Medicines (RVMD) Shares Issued (2019 - 2026)
Revolution Medicines' quarterly Shares Issued came in at $57000.0 in Q1 2026, down 93.6% year-on-year from $891000.0 in Q1 2025, and down 99.98% quarter-over-quarter from $340.9 million in Q4 2025.
Revolution Medicines has reported Shares Issued for 8 years, with the latest figure at $57000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued fell 93.6% year-over-year to $57000.0; the trailing twelve-month figure through Mar 2026 stood at $347.1 million (up 474.7% YoY), and the FY2025 full-year result was $347.9 million, up 484.71% from the prior year.
- Shares Issued for Q1 2026 stood at $57000.0, down from $340.9 million in the prior quarter.
- The five-year high for Shares Issued was $340.9 million in Q4 2025, with the low at -$320.4 million in Q4 2023.
- Average Shares Issued over 5 years is $33.9 million, with a median of $834000.0 recorded in 2022.
- Peak annual rise in Shares Issued reached 106031.15% in 2023, while the deepest fall reached 41334.23% in 2023.
- Tracing RVMD's Shares Issued over 5 years: stood at $777000.0 in 2022, then plunged by 41334.23% to -$320.4 million in 2023, then jumped by 116.03% to $51.3 million in 2024, then soared by 563.94% to $340.9 million in 2025, then plunged by 99.98% to $57000.0 in 2026.
- The last three Shares Issued figures came in at $57000.0 (Q1 2026), $340.9 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,000.00 |
| Mar 31, 2026 | 57,000.00 |
| Dec 31, 2025 | 340.93 Mn |
| Dec 31, 2025 | 340.93 Mn |
| Sep 30, 2025 | 6.97 Mn |
| Sep 30, 2025 | 6.97 Mn |
| Jun 30, 2025 | -890,000.00 |
| Jun 30, 2025 | -890,000.00 |
| Mar 31, 2025 | 891,000.00 |
| Mar 31, 2025 | 891,000.00 |
| Dec 31, 2024 | 51.35 Mn |
| Dec 31, 2024 | 51.35 Mn |
| Sep 30, 2024 | 8.15 Mn |
| Sep 30, 2024 | 8.15 Mn |
| Dec 31, 2023 | -320.39 Mn |
| Dec 31, 2023 | -320.39 Mn |
| Jun 30, 2023 | 62.10 Mn |
| Jun 30, 2023 | 62.10 Mn |
| Mar 31, 2023 | 323.70 Mn |
| Mar 31, 2023 | 323.70 Mn |
| Dec 31, 2022 | 777,000.00 |
| Dec 31, 2022 | 777,000.00 |
| Sep 30, 2022 | 704,000.00 |
| Sep 30, 2022 | 704,000.00 |
| Jun 30, 2022 | -305,000.00 |
| Jun 30, 2022 | -305,000.00 |
| Mar 31, 2022 | 305,000.00 |
| Mar 31, 2022 | 305,000.00 |
| Sep 30, 2021 | 280.33 Mn |
| Sep 30, 2021 | 280.33 Mn |
| Jun 30, 2021 | -280.90 Mn |
| Jun 30, 2021 | -280.90 Mn |
| Mar 31, 2021 | 281.71 Mn |
| Mar 31, 2021 | 281.71 Mn |
| Dec 31, 2020 | -34,000.00 |
| Dec 31, 2020 | -34,000.00 |
| Sep 30, 2020 | 419.99 Mn |
| Sep 30, 2020 | 419.99 Mn |
| Jun 30, 2020 | -253.60 Mn |
| Jun 30, 2020 | -253.60 Mn |
| Mar 31, 2020 | 253.72 Mn |
| Mar 31, 2020 | 253.72 Mn |
| Dec 31, 2019 | 50,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Sep 30, 2019 | 212,000.00 |
| Sep 30, 2019 | 212,000.00 |
| Jun 30, 2019 | 1,000.00 |
| Jun 30, 2019 | 1,000.00 |
| Mar 31, 2019 | 14,000.00 |
| Mar 31, 2019 | 14,000.00 |